Walleye Trading LLC Ardelyx, Inc. Transaction History

Walleye Trading LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$1.66 - $4.16 $3,320 - $8,320	-2,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$3.75 - $4.65 $37,500 - $46,500	-10,000 Reduced 83.33%	2,000 $9,000
Q2 2018 Aug 14, 2018	BUY	$3.7 - $5.8 $44,400 - $69,600	12,000 New	12,000 $44,000
Q4 2017 Feb 14, 2018	SELL	$4.85 - $7.8 $54,741 - $88,038	-11,287 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$4.35 - $5.7 $120,059 - $157,320	-27,600 Reduced 70.97%	11,287 $63,000
Q2 2017 Aug 14, 2017	BUY	N/A	38,887	38,887 $198,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $804M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.